Show simple item record

Inhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness.

dc.contributor.authorTutt, A
dc.date.accessioned2018-01-24T11:27:18Z
dc.date.issued2018-01-01
dc.identifier.citationAnnals of oncology : official journal of the European Society for Medical Oncology, 2018, 29 (1), pp. 18 - 21
dc.identifier.issn0923-7534
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1010
dc.identifier.eissn1569-8041
dc.identifier.doi10.1093/annonc/mdx775
dc.formatPrint
dc.format.extent18 - 21
dc.languageeng
dc.language.isoeng
dc.publisherOXFORD UNIV PRESS
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectBreast Neoplasms
dc.subjectNeoplasm Recurrence, Local
dc.subjectPaclitaxel
dc.subjectCarboplatin
dc.subjectBenzimidazoles
dc.subjectTemozolomide
dc.titleInhibited, trapped or adducted: the optimal selective synthetic lethal mix for BRCAness.
dc.typeJournal Article
dcterms.dateAccepted2017-10-18
rioxxterms.versionofrecord10.1093/annonc/mdx775
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by-nc/4.0
rioxxterms.licenseref.startdate2018-01
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfAnnals of oncology : official journal of the European Society for Medical Oncology
pubs.issue1
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR
pubs.publication-statusPublished
pubs.volume29
pubs.embargo.termsNot known
dc.contributor.icrauthorTutt, Andrew


Files in this item

Thumbnail
Name:
mdx775.pdf
Size:
70.48Kb
Format:
PDF
Description:
Accepted version
View/Open

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0